A study of the teratogenic and fetotoxic effects of large doses of barbital,hexobarbital and butobarbital used for suicide attempts by pregnant women

Abstract

The teratogenic potential of barbiturates is debated. The objective of this study was to evaluate the effects of very large doses of different barbiturates, except phenobarbital and amobarbital, on fetal development in pregnant women who attempted suicide. These self-poisoned pregnant women were identified among the patients of the Department of Toxicology Internal Medicine, Korányi Hospital, Budapest. The prevalence at birth of congenital abnormalities and intrauterine fetal growth, based on pregnancy age at delivery and birth weight, as well as cognitive-behavioral status in exposed children born to mothers who attempted suicide with barbiturates alone or in combination with other drugs, during pregnancy, were compared with their sibs as controls. Of 1044 women with self-poisoning during pregnancy between 1960 and 1993, 411 delivered live-born babies; of these, 367 (89.3%) exposed children were evaluated. Of the 367 exposed children, 6, 5, 4 and 4 were born to mothers who attempted suicide with very large doses of Barbamid^® (butobarbital and aminophenazone), hexobarbital, butobarbital and Belloid^® (butobarbital, hyoscyamine and secalis cornuti alkaloida) tablets, respectively. Of 19 exposed children, two children with a congenital inguinal hernia were born to mothers who attempted suicide with 30 tablets of Belloid^® (900 mg butobarbital) in the 20th postconceptional week or with 20 tablets of Belloid^® in combination with chlordiazepoxide (100 mg) and nitrazepam (100 mg) in 12th postconceptional week. However, the critical period for production of congenital inguinal hernia is in the last months of pregnancy. None of the exposed children born to the other 12 pregnant women who attempted suicide with these barbiturates between the third and 12th postconceptional week, i.e., during the critical period for production of most major congenital abnormalities, had a congenital abnormality. Congenital abnormalities did not occur among 16 sib controls. Intrauterine fetal growth was similar between sibs and exposed children; cognitive status and behavioral scale also did not indicate any neurotoxic effects from large doses of these barbiturates. The very large doses of barbital, hexobarbital and/or butobarbital used for self-poisoning during pregnancy were not teratogenic to the children, although it must be recognized that the number of exposed children was limited.

Keywords

barbital hexobarbital butobarbital congenital abnormalities birth weight pregnancy age cognitive status behavioral development suicide attempt during pregnancy

Get full access to this article

View all access options for this article.

References

Briggs GG Freeman RK Yaffe SJ (2005) Drugs in Pregnancy and Lactation, seventh ed. Philadelphia: Lipincott Williams and Wilkins.

Czeizel AE (1986) Self-poisoning as a model for the study of mutagenicity and teratogenicity of chemicals on human beings. In: C Ramel B Lambert J Magnusson . (eds), Genetic Toxicology of Environmental Chemicals. Part B: Genetic Effects and Applied Mutagenesis. New York: Alan R. Liss, pp. 237–244.

Czeizel AE (1994) Budapest registry of self-poisoned patients. Mutat Res 312: 157–163.

Czeizel AE Bod M Halász P (1992) Evaluation of anticonvulsant drugs during pregnancy in a population-based Hungarian study. Eur J Epidemiol 8: 122–127.

Czeizel AE Gidai J Petik D Timmermann G Puhó EH (2008) Self-poisoning during pregnancy as a model for teratogenic risk estimation of drugs. Toxicol Ind Health 24: 11–28.

Czeizel AE Lendvay A (1989) Attempted suicide and pregnancy. Am J Obstet Gynecol 161: 497.

Czeizel AE Petik D Puhó E (2004) Smoking and alcohol drinking during pregnancy: the validity of retrospective maternal self-reported information. Cent Eur J Publ Health 12: 179–183.

Czeizel AE Rockenbauer M Siffel CS Varga E (2001) Description and mission evaluation of the Hungarian case-control surveillance of congenital abnormalities, 1980–1996. Teratology 63: 176–185.

Czeizel AE Szentesi I Szekeres I Glauber A Bucski P Molnár C (1984) Pregnancy outcome and health conditions of offspring of self-poisoned pregnant women. Acta Paediatr Hung 25: 209–236.

10.

Czeizel AE Szentesi I Szekeres I Molnár G Glauber A Bucski P (1988) A study of adverse effects on the progeny after intoxication during pregnancy. Arch Toxicol 62: 1–7.

11.

Czeizel AE Tomcsik J Tímár L (1997) Teratologic evaluation of 178 infants born to mothers who attempted suicide by drugs during pregnancy. Obstet Gynecol 90: 195–201.

12.

Dobson Sz (2002) Phenobarbital, phenytoin. In: Dobson, Sz, (ed), Milestone in the History of Pharmaceutical Therapy. Budapest: (Hungarian) Dictum Publ., pp. 13–15.

13.

Draffan GH Dollery CT Davies DS (1976) Maternal and neonatal elimination of amobarbital after treatment of the mother with barbiturates during late pregnancy. Clin Pharmacol Ther 19: 271–275.

14.

FDA : Food and Drug Administration (1980) Fetal Risk Summary. Federal Register 44: 37434–37467.

15.

Friedman JM Polifka JE (1996) The Effects of Drugs on the Fetus and Nursing Infants. Baltimore: Johns Hopkins University Press.

16.

Janz D Fuchs V (1964) Are anti-epileptic drugs harmful when given during pregnancy? German Med Monogr 9: 20–23.

17.

Kraver B Draffan GH Williams FM (1973) Elimination kinetics of amobarbital in mothers and newborn infants. Clin Pharmacol Ther 14: 442–447.

18.

Lendvay A Czeizel AE (1992) A behavioural teratologic study on offspring of self-poisoned pregnant women. Acta Paediatr Hung 32: 347–369.

19.

Petik D Timmermann G Czeizel AE Ács N Bánhidy F (2008) A study of teratogenic and fetotoxic effect of large doses of amobarbital used for a suicide attempt by 14 pregnant women. Toxic Ind Health 79–85.

20.

Shepard TH Lemire RJ (2004) Catalog of Teratogenic Agents, eleventh ed. Baltimore: Johns Hopkins University Press.

21.

Szegal B (1980) Diagnostic of psychomotor development. Hung Psychol 37: 148–188.